BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29799646)

  • 1. Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis.
    Elias PM
    Exp Dermatol; 2018 Aug; 27(8):847-851. PubMed ID: 29799646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier repair therapy in atopic dermatitis: an overview.
    Hon KL; Leung AK; Barankin B
    Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
    Kubo A; Nagao K; Amagai M
    J Clin Invest; 2012 Feb; 122(2):440-7. PubMed ID: 22293182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.
    van Smeden J; Bouwstra JA
    Curr Probl Dermatol; 2016; 49():8-26. PubMed ID: 26844894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
    Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
    J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the epidermal barrier in atopic dermatitis.
    Proksch E; Fölster-Holst R; Bräutigam M; Sepehrmanesh M; Pfeiffer S; Jensen JM
    J Dtsch Dermatol Ges; 2009 Oct; 7(10):899-910. PubMed ID: 19682176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis.
    Wolf R; Wolf D
    Clin Dermatol; 2012; 30(3):329-34. PubMed ID: 22507048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eczema and ceramides: an update.
    Jungersted JM; Agner T
    Contact Dermatitis; 2013 Aug; 69(2):65-71. PubMed ID: 23869725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.
    Elias PM; Wakefield JS
    J Allergy Clin Immunol; 2014 Oct; 134(4):781-791.e1. PubMed ID: 25131691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review.
    Huet F; Severino-Freire M; Chéret J; Gouin O; Praneuf J; Pierre O; Misery L; Le Gall-Ianotto C
    J Dermatol Sci; 2018 Mar; 89(3):213-218. PubMed ID: 29248403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutations within the filaggrin gene and atopic dermatitis.
    Kawasaki H; Kubo A; Sasaki T; Amagai M
    Curr Probl Dermatol; 2011; 41():35-46. PubMed ID: 21576945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
    Elias PM; Wakefield JS
    Clin Rev Allergy Immunol; 2011 Dec; 41(3):282-95. PubMed ID: 21174234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
    Elias PM; Wakefield JS; Man MQ
    Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.
    Thyssen JP; Kezic S
    J Allergy Clin Immunol; 2014 Oct; 134(4):792-9. PubMed ID: 25065719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
    Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
    Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing emollient therapy for skin barrier repair in atopic dermatitis.
    Elias PM
    Ann Allergy Asthma Immunol; 2022 May; 128(5):505-511. PubMed ID: 35065300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
    Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
    Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin barrier in atopic dermatitis.
    Kezic S; Novak N; Jakasa I; Jungersted JM; Simon M; Brandner JM; Middelkamp-Hup MA; Weidinger S
    Front Biosci (Landmark Ed); 2014 Jan; 19(3):542-56. PubMed ID: 24389202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filaggrin mutations and atopy: consequences for future therapeutics.
    Heimall J; Spergel JM
    Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron diffraction study of lipids in non-lesional stratum corneum of atopic eczema patients.
    Janssens M; Mulder AA; van Smeden J; Pilgram GS; Wolterbeek R; Lavrijsen AP; Koning RI; Koster AJ; Bouwstra JA
    Biochim Biophys Acta; 2013 Aug; 1828(8):1814-21. PubMed ID: 23583924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.